3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
2
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Breast Neoplasms
3865
Neoplasms
2990
Prostatic Neoplasms
1754
Colorectal Neoplasms
1431
Lung Neoplasms
1331
Motor Activity
805
Head and Neck Neoplasms
686
Pancreatic Neoplasms
663
Colonic Neoplasms
655
Uterine Cervical Neoplasms
653
Carcinoma, Hepatocellular
632
Carcinoma, Non-Small-Cell Lung
631
Rectal Neoplasms
571
Stomach Neoplasms
547
Brain Neoplasms
486
Ovarian Neoplasms
441
Anxiety Disorders
420
Pain
419
Neoplasm Metastasis
385
Esophageal Neoplasms
384
Polycystic Ovary Syndrome
376
Precursor Cell Lymphoblastic Leukemia-Lymphoma
354
Urinary Bladder Neoplasms
351
Fatigue
340
Melanoma
323
Multiple Myeloma
322
Lymphoma
306
Depression
306
Endometrial Neoplasms
290
Liver Neoplasms
280
Interventions
posaconazole
1
Fluconazole
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Interventional
×
Aspergillosis
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled
NCT02955966
2025-11-20
OPTIFIL
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
51 enrolled